Application for quotation of securities - BLS

Oct 4, 2026 at 8:46 PM EDT · Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · Oct 4, 2026 at 8:46 PM EDT · 6 pages · English

On 6ix: 6ix.com/news/application-for-quotation-of-securities-bls-1

Release

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameBLS PHARMACEUTICALS LIMITEDAnnouncement TypeNew announcementDate of this announcementMonday October 05, 2026The +securities to be quoted are:Total number of...

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

Initial Director's Interest NoticeSep 14
Angus Walker Appointed Alternate Director to Edward MyerSep 13
S&P DJI Announces September 2026 Quarterly RebalanceSep 4
Appendix 4G Corporate Governance StatementAug 31
BLS FY2027 GuidanceAug 30

Later from BLS Pharmaceuticals

AGM Date and Director NominationsOct 6
Becoming a substantial holderOct 8
Ceasing to be a substantial holderOct 12
Quarterly Activities/Appendix 4C Cash Flow ReportOct 14
BLS Quarterly Activities Report September 2026 RevisedOct 14

All BLS Pharmaceuticals news releases

Follow BLS Pharmaceuticals into a list and get an email when it puts out news.

Follow BLS Pharmaceuticals